TrialTargeted oncology2017

Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).

Joleen M Hubbard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.